Get the Stockscreener App
130.22
0.31%
-0.41
After Hours:
131.01
0.79
+0.61%
Overview
News
Price History
Option Chain
Financials
Why RVTY Down?
Discussions
Forecast
Stock Split
Dividend History
Revvity Inc stock is traded at $130.22, with a volume of 1.17M.
It is down -0.31% in the last 24 hours and up +16.90% over the past month.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
See More
Previous Close:
$130.63
Open:
$130.03
24h Volume:
1.17M
Relative Volume:
0.79
Market Cap:
$14.53B
Revenue:
$2.90B
Net Income/Loss:
$239.11M
P/E Ratio:
61.72
EPS:
2.1097
Net Cash Flow:
$492.62M
1W Performance:
+1.10%
1M Performance:
+16.90%
6M Performance:
+32.22%
1Y Performance:
+51.95%
1-Day Range:
$129.56
$131.70
1-Week Range:
$125.46
$133.00
52-Week Range:
$81.22
$133.00
Revvity Inc Stock (RVTY) Company Profile
Name
Revvity Inc
Sector
Industry
Phone
781-663-6900
Address
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, NTRA, IQV, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
130.22 | 13.85B | 2.90B | 239.11M | 492.62M | 2.1097 |
TMO
Thermo Fisher Scientific Inc
|
613.78 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
207.66 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
328.18 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
IQV
Iqvia Holdings Inc
|
267.77 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
150.86 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-14-26 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-15-25 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-09-25 | Initiated | Goldman | Neutral |
| Oct-16-25 | Initiated | Guggenheim | Neutral |
| May-01-25 | Upgrade | UBS | Neutral → Buy |
| Jan-10-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jul-08-24 | Initiated | Leerink Partners | Outperform |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | UBS | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-23-23 | Resumed | Goldman | Buy |
View All
Revvity Inc Stock (RVTY) Latest News
Revvity Inc. stock holds above 130 dollars as analysts stick with Hold ratings - AD HOC NEWS
Revvity, Inc. (RVTY) Stock Analysis: Navigating Potential in the Diagnostics Sector Amid Mixed Ratings - DirectorsTalk Interviews
KeyBanc Maintains Revvity(RVTY.US) With Buy Rating, Raises Target Price to $165 - Moomoo
Is Revvity Stock a Buy as Growth Improves but Valuation Stays Rich? - Yahoo Finance
KeyBanc Adjusts Price Target on Revvity to $165 From $125, Maintains Overweight Rating - marketscreener.com
Global Multiplex Assays Market 2026 Edition - GlobeNewswire Inc.
Revvity Inc. stock holds near 52-week high as valuation debate intensifies - AD HOC NEWS
Baird Adjusts Price Target on Revvity to $144 From $131, Keeps Outperform Rating - marketscreener.com
Revvity (RVTY) Stock Looks Fair On Cash Flow Yet Pricey On Earnings - Yahoo Finance
Revvity Inc (RVTY) Stock Up 3.4% but GF Value Says Overvalued -- GF Score: 77/100 - GuruFocus
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Revvity (RVTY) Margins Story Faces A Valuation Test Following Its Zacks Upgrade - Yahoo Finance
What Makes Revvity (RVTY) a New Buy Stock - Yahoo Finance
Revvity Faces Growth Challenges Amid Rising Competition, RBC Says - marketscreener.com
RBC Initiates Revvity at Sector Perform With $135 Price Target - marketscreener.com
RBC Capital initiates Revvity stock with Sector Perform rating By Investing.com - Investing.com Australia
RBC Capital initiates Revvity stock with Sector Perform rating - Investing.com
Revvity, Inc. (RVTY) Stock Analysis: Navigating a 6% Potential Downside with Strategic Insights - DirectorsTalk Interviews
Revvity Inc stock hits 52-week high at 130.07 USD - Investing.com
RVTY Stock Price and Chart — NYSE:RVTY - TradingView
Revvity (NYSE: RVTY) director donates 285 shares in stock gift - Stock Titan
Revvity, Inc. (RVTY) Stock Analysis: Healthcare Innovator With Mixed Growth Signals - DirectorsTalk Interviews
Revvity stock trades around $123 as investors weigh latest earnings and analyst targets - Ad-hoc-news.de
Why Revvity (RVTY) Stock Is Up Today - Quiver Quantitative
Revvity stock hits new 52-week high as gains extend - Ad-hoc-news.de
Revvity stock hits 52-week high at 122.26 USD - Investing.com
Revvity stock hits 52-week high at 122.26 USD By Investing.com - Investing.com India
Revvity Inc (RVTY) Shares Surge 5.0% -- What GF Score of 78 Tells Investors - GuruFocus
Revvity Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
Revvity stock edges lower as SuperFlex launch and Q2 earnings shape valuation debate - Ad-hoc-news.de
Revvity Inc (RVTY) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Revvity Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Revvity (NYSE: RVTY) executive gifts 27,785 shares to trust - Stock Titan
Revvity (NYSE:RVTY) Gains Attention After SuperFlex Launch - Kalkine Media
Revvity CEO Prahlad Singh Transfers Over 67,000 Shares to Family Trusts in Gift Transactions - Kalkine Media
Revvity (NYSE: RVTY) CEO shifts stock into family trusts at $0 - Stock Titan
Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Innovator with Modest Upside and Resilient Performance - DirectorsTalk Interviews
Revvity (NYSE:RVTY) Downgraded by Wall Street Zen to "Hold" - MarketBeat
T. Rowe Price (RVTY) reports 16.4% Revvity stake, 18.3M shares under control - Stock Titan
T. Rowe Price Associates (RVTY) discloses 5.0% beneficial stake in Revvity - Stock Titan
Revvity Launches SuperFlex Prenatal Screening System for Smaller Labs - Zacks Investment Research
Revvity (NYSE:RVTY) Hits New 12-Month HighWhat's Next? - MarketBeat
Revvyty Inc stock hits 52-week high at 118.34 USD By Investing.com - Investing.com South Africa
Revvity Inc. (NYSE:RVTY) Given Average Recommendation of "Hold" by Analysts - MarketBeat
The Top 5 Analyst Questions From Revvity’s Q2 Earnings Call - Yahoo Finance
Revvity, Inc. (RVTY) Stock Forecasts - Yahoo Finance
Understanding the Setup: (RVTY) and Scalable Risk - Stock Traders Daily
Taylor Farms Recall Puts Food Safety Stocks On Retail Investors Radar - sahmcapital.com
RVTY SWOT Analysis: Strong Revenue Growth Amidst Market Challenges Revealed in 10-Q Filing - GuruFocus
Revvity : Quarterly Report for Quarter Ending July 5, 2026 (Form 10-Q) - marketscreener.com
Revvity (RVTY) grows Q2 revenue, boosts cash and plans China diagnostics exit - Stock Titan
Revvity Inc Stock (RVTY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.39%
1.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):